Case Presentation: fulminant hepatic failure
Michelle Y. Braunfeld – 30 December 2003
Complications of liver transplantation: A perioperative perspective
William T. Merritt – 30 December 2003
Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites
James F. Trotter, Paul V. Suhocki – 30 December 2003 – Transjugular intrahepatic portosystemic shunt (TIPS) is an effective therapy for patients with medically refractory ascites. Many patients with refractory ascites have umbilical herniation. Incarceration of umbilical hernia has been reported following diuresis, paracentesis, and peritoneovenous shunting. We report 2 cases of umbilical hernia incarceration following resolution of ascites after TIPS.
Living related liver transplantation for acute liver failure in children
Sukru Emre, Myron E. Schwartz, Benjamin Shneider, Joanne Hojsak, Leona Kim‐Schluger, Thomas M. Fishbein, Stephen R. Guy, Patricia A. Sheiner, Neal S. LeLeiko, Audrey Birnbaum, Frederick J. Suchy, Charles M. Miller – 30 December 2003 – The mortality rate among children with acute liver failure (ALF) on the waiting list for liver transplantation is high. We present our experience with living related donor liver transplantation (LRD‐LT) in children who required urgent transplantation for ALF. Between December 1995 and July 1997, 6 children underwent LRD‐LT for ALF.
Posttransplantation lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome
Ziv Ben‐Ari, Peter Amlot, Surech R. Lachmanan, Ran Tur‐Kaspa, Keith Rolles, Andrew K. Burroughs – 30 December 2003 – Posttransplantation lymphoproliferative disorder (PTLD) is a well‐recognized complication of organ transplantation. The aim of this study, performed over 9 years, was to examine the histopathological findings, clinical course, and outcome of patients who, having undergone orthotopic liver transplantation (OLT), developed PTLD.
Maximum sharing of cadaver liver grafts composite split and domino liver transplants
- Read more about Maximum sharing of cadaver liver grafts composite split and domino liver transplants
Linhares Furtado, Fernando Oliveira, Emanuel Furtado, Batista Geraldes, Aurélio Reis, Joaquim Viana, Carlos Bento, Helena Vieira, Silvia Neves – 30 December 2003
Comparison of pharmacokinetics of neoral and sandimmune in stable pediatric liver transplant recipients
Indra D. M. van Mourik, Mike Thomson, Deirdre A. Kelly – 30 December 2003 – Cyclosporine (Sandimmune; Novartis Pharmaceuticals UK Ltd) is an effective immunosuppressive drug, but its lipid formulation and variable absorption may expose children to the risk of rejection during episodes of gastroenteritis after liver transplantation. Neoral (Novartis) is a microemulsified form of cyclosporine that may be better absorbed.
Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: A case series
Kia Saeian, José Franco, Richard A. Komorowski, Mark B. Adams – 30 December 2003 – The occurrence of hepatocellular carcinoma (HCC) in renal transplant recipients has typically been associated with hepatitis B or C infection. We encountered two cases of HCC in renal transplant recipients with negative hepatitis B and C markers and no underlying liver pathology, in whom immunosuppression therapy consisted of prednisone and azathioprine (AZA). Patient no. 1 is a 66‐year‐old man with diabetes who underwent cadaveric renal transplantation 13 years before presentation.